Pharmaceuticals
CCI Imposes Rs64 crore fine on GlaxoSmithKline, Sanofi
06 Jun 2015
CCI order comes on a complaint by Bio-Med, which alleged that GlaxoSmithKline and Sanofi collided in the tendering for meningitis vaccines in contravention of the provisions of the anti-trust Act, with passive help from the government
First-ever successful skull and scalp transplant reported
05 Jun 2015
This kind of a triple transplant has never been reported before where just the skull and the scalp have been surgically transplanted
Teva pressures takeover target Mylan with 1.8% stake buy
03 Jun 2015
Analysts expect Teva to make a sweetened formal bid for Mylan after raising its stake to the 4.6 per cent threshold, because once it tables a formal bid, it cannot buy Mylan shares from the market
Teva settles US antitrust charges for $1.2 bn
29 May 2015
The world’s biggest generic drug maker Israel’s Teva Pharmaceutical Industries has agreed to settle US antitrust charges for illegally blocking competition to its blockbuster sleep-disorder drug Provigil
Diabetes screening will overwhelm India's health system: study
20 May 2015
A large-scale diabetes screening programme underway in India will overwhelm the health system with false positive results, warn researchers
Pfizer is unnamed bidder for Swedish rare disease firm Orphan Biovitrum
02 May 2015
Pfizer’s interest in rare diseases first became evident in December 2009, when the company licensed the worldwide rights to taliglucerase alfa, a product that treats the genetic disorder Gaucher disease
Biocon Q4 net profit surges 78% to Rs202 cr
30 Apr 2015
Perrigo rejects Mylan’s latest $34.10 bn bid
30 Apr 2015
The rejection from Perrigo comes as Mylan fends off an unsolicited $40-billion takeover bid from Israeli generic drug giant Teva Pharmaceuticals
Mylan raises bid for Perrigo Co to $34.10 bn
29 Apr 2015
As a result of the increased offer, Mylan will own approximately 60.7 per cent of the merged company, while the remaining 39.3 per cent will be held by Perrigo
Featured articles
![](/Uploads/Images/thumb_733d509d-493c-41e9-b429-1260d912bb91-Aerogel-Crayon.jpg)
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
![](/Uploads/Images/thumb_294b0bec-6ff0-43c9-9fbc-a14e7cc70fa5-COP28.jpg)
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
![](/Uploads/Images/thumb_97943c9b-6e8f-429b-b355-1d4502bac437-Ponzi-Money.jpg)
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
![](/Uploads/Images/thumb_0f8359a3-2528-4faf-86c9-707fb7bccc01-Hdfc-logo.jpg)
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
![](/Uploads/Images/thumb_dc6b9dcc-e31e-4574-82e7-928e089406e0-Finger_millet.jpg)
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
![](/Uploads/Images/thumb_e37827da-fafd-4991-8635-60fade3df34c-ICM.jpg)
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation